论文部分内容阅读
来自于日本 Tularik 有限公司与冷泉港实验室的研究人员发现一种被称作 KCNK9的新基因可在近50%的乳腺癌标本中高水平异常表达,且该基因在近35%的肺癌标本中也有类似的过量表达。该研究发现的重要意义有以下几点:KCNK9基因揭示了一个早先未被发现的致癌
Researchers from Japan’s Tularik Co. Ltd. and Cold Spring Harbor Laboratory found that a new gene, called KCNK9, is abnormally expressed at high levels in nearly 50% of breast cancer specimens and is found in nearly 35% of lung cancer specimens Similar overexpression. The significance of this study is as follows: The KCNK9 gene revealed a previously undiscovered carcinogen